7th annual anti cancer drug discovert & development summit
Venue: Sheraton Boston
|Event Date/Time: Jul 12, 2005||End Date/Time: Jul 13, 2005|
The 7th Anti-Cancer Drug Discovery and Development Summit consists of the finest group of oncology experts from around the world to address the most promising avenues of investigation. An agenda well-balanced with therapeutic discovery & development programs coming from big pharma, biotechs & academia - this is the series most widely attended by high-level industrial cancer researchers, academic professors, and business development personnel worldwide since 1999, year after year.
What’s New at the 2005 Summit:
Latest Studies on Targeted Therapeutics:
Updated Data on Angiogenesis Inhibitors, Antibodies & New Targets:
Special Focus on Licensing, Partnering and Acquisitions in Oncology Business Development - See Day Two, Track B!
Featured Keynote Address:
The Challenges in Developing New Cancer Therapies
Global Medical Science Director, Oncology
ASTRAZENECA R&D BOSTON
Actinium Pharmaceuticals, Inc.
AstraZeneca R&D Boston
Biomarker Technologies, LLC
Biovest International - An Accentia Company
Bristol Myers Squibb Company
Celgene San Diego
Decision Options, LLC
Johnson & Johnson Pharmaceutical R&D
Merck Research Laboratories
OSI Pharmaceuticals, Inc.
Pfizer Global Research & Development - Ann Arbor
Proctor & Gamble Pharmaceuticals
Sherris Pharma Partners
Veridex, LLC - A Johnson & Johnson Company
Dartmouth Medical School
Harvard Medical School Institute of Proteomics
UCLA David Geffen School of Medicine
University of Texas Southwestern Medical Center